Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
Actual shortage: | 228 (8%) | |
Anticipated shortage: | 1 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 253 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
TEVA-DILTIAZEM | 60MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103773 |
TEVA-TERAZOSIN | 2MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103776 |
TEVA-SELEGILINE | 5MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103814 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
TEVA-ATENOLOL | 25MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104310 |
TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104319 |
TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104330 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104333 |
TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104347 |
TEVA-TIAPROFENIC ACID | 300MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104350 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-01-24 | 2020-04-09 | 104356 |
TEVA-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-01-24 | 2021-01-28 | 104374 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2020-01-30 | 2020-02-13 | 104884 |
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2020-01-30 | 2020-02-13 | 104890 |
TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
TEVA-LACOSAMIDE | 150MG | TABLET | Resolved | 2020-01-30 | 2020-04-02 | 104899 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-01-30 | 2020-06-11 | 104908 |
TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-02-07 | 2020-04-09 | 105561 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97235 |
TEVA-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97238 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |